查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2160723

實驗室自動化和高通量篩檢市場預測至2034年—按產品類型、應用、最終用戶和地區分類的全球分析

Laboratory Automation & High-Throughput Screening Market Forecasts to 2034 - Global Analysis By Product Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球實驗室自動化和高通量篩檢市場規模將達到 348 億美元，並在預測期內以 8.9% 的複合年成長率成長，到 2034 年將達到 689 億美元。

實驗室自動化和高通量篩檢結合了機器人技術、自動化設備、軟體平台和分析技術，旨在提高實驗室操作的效率和準確性。這些解決方案可自動完成樣品製備、液體處理、檢測執行、數據採集和結果分析等任務。高通量篩檢使研究人員能夠在更短的時間內探索龐大的化合物庫、樣品和實驗變數。透過最大限度地減少人工操作，這些技術提高了工作流程的一致性、可重複性、處理能力和操作效率，同時加速了製藥、生物技術、臨床和學術領域實驗室的研究活動和藥物發現進程。

據美國國立衛生研究院 (NIH) 下屬的國家轉化科學促進中心 (NCATS) 稱，該中心的自動化篩檢系統可容納超過 300 萬個化合物孔和約 150 萬個檢測孔，從而可以並行運行多個檢測。

對實驗室效率和生產力的需求日益成長

隨著對實驗室效率和生產力的日益重視，各機構對更快、更可靠的工作流程提出了更高的要求，從而推動了市場擴張。自動化技術能夠處理重複性的實驗室任務，減少人為干預，並維持一致的處理標準。製藥和生物技術公司正擴大利用這些功能來縮短實驗週期並實現操作標準化。隨著實驗室將生產力、營運最佳化和減少處理延遲作為優先事項，自動化和高通量篩檢解決方案在研發和測試環境中的應用持續成長。

高昂的初始投資和實施成本

實驗室自動化前期投入成本高昂，可能會阻礙市場普及，尤其對於預算有限的機構而言更是如此。機器人設備、自動化分析儀、軟體、基礎設施和系統整合都需要大量投資。此外，安裝、驗證、維護、技術升級和員工培訓等額外成本也會增加整體實施成本。而且，將新的自動化平台整合到現有實驗室流程中可能涉及技術複雜性、額外資源和較長的實施週期，這可能會延緩向自動化和高通量實驗室操作的過渡。

新興市場自動化擴張

開發中國家檢查室自動化技術的日益普及蘊藏著巨大的市場成長潛力。在製藥、生物技術、診斷和學術研究活動不斷成長的推動下，檢查室正尋求透過自動化技術提高營運效率。醫療基礎設施的改善以及對研發和生物技術設施的投資，預計將進一步加速技術的應用。隨著新興經濟檢查室的現代化進程，技術供應商有機會提供擴充性且經濟高效的自動化解決方案，以滿足日益成長的高效檢測、篩檢和研究需求。

與資料安全和系統漏洞相關的風險

網路安全問題可能威脅到連網檢查室自動化系統和高通量篩檢系統的應用。現代檢查室擴大使用連網設備、數位平台、雲端技術和集中式資料環境，這些都可能導致未授權存取和網路安全事件的發生。安全漏洞可能導致敏感的研究資訊、智慧財產權、實驗結果和運行資料外洩。因此，各機構可能需要更強大的安全基礎設施、監控和防護措施，而由此帶來的成本增加和技術複雜性可能會延緩日益互聯的檢查室自動化解決方案的採用。

新型冠狀病毒（COVID-19）的影響：

新冠疫情加速了實驗室自動化和高通量篩檢的需求，因為實驗室需要更快的檢測速度、更高的處理能力以及更少的人工干預。製藥公司和研究機構也加強了篩檢力度，專注於疫苗、療法和診斷解決方案。由於供應鏈挑戰和營運限制，設備的交付和安裝一度受到影響。然而，疫情凸顯了自動化的優勢，並促使人們進一步投資於擴充性、高效的實驗室技術，以滿足未來的研究和檢測需求。

在預測期內，自動化液體處理系統細分市場預計將佔據最大的市場佔有率。

預計在預測期內，自動化液體處理系統將佔據最大的市場佔有率，因為它支援實驗室中涉及液體精確可靠轉移的關鍵流程。這些系統透過自動化移液、分液、稀釋和樣品製備，最大限度地減少了重複的人工操作，並提高了實驗的一致性。其廣泛應用源自於其在藥物發現、藥物開發、生物技術、基因組學和臨床試驗等眾多領域的效用。此外，與機器人儀器和高通量篩檢平台的兼容性也增強了這些系統在自動化工作流程中的作用。

預計在預測期內，合約研究組織（CRO）細分市場將呈現最高的複合年成長率。

在預測期內，受製藥和生技公司日益依賴外部供應商滿足其研發和測試需求的強勁成長推動，合約研究組織 (CRO) 領域預計將呈現最高的成長率。 CRO 需要高度擴充性的技術來有效處理海量樣本、實驗工作量和篩檢項目。自動化使這些機構能夠提高處理能力、最大限度地減少重複性任務、保持標準化流程並縮短專案週期。藥物發現、臨床前試驗、分析服務和專業研究活動的日益外包也促使 CRO 採用先進的實驗室自動化和高通量篩檢技術。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其成熟的製藥和生物技術產業、先進的研發能力以及自動化實驗室解決方案的廣泛應用。該地區眾多研究機構、臨床檢查室和合約研究組織（CRO）都依賴自動化技術來改善實驗室流程。此外，完善的醫療保健基礎設施和強大的實驗室技術公司網路也鞏固了北美在自動化和高通量篩檢應用領域的領先地位。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率，這主要得益於製藥、生物技術和研究活動的持續擴張。對藥物研發、臨床試驗、基因組學和先進診斷能力的投資增加，進一步推動了檢查室自動化的需求。醫療基礎設施的改善、先進研究技術的廣泛應用以及檢測服務外包的增加，也進一步促進了自動化技術的應用。生物技術中心的擴張和全部區域研究生態系統的強化，正促使實驗室部署自動化平台，以提高效率、擴充性和高通量篩檢能力。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球實驗室自動化與高通量篩檢市場：依產品類型分類

  • 自動液體處理系統
  • 自動盤式分析儀
  • 自動化儲存和檢索系統
  • 機器人系統
  • 實驗室資訊管理系統（LIMS）
  • 高通量篩檢裝置

第6章 全球實驗室自動化與高通量篩檢市場：依應用領域分類

  • 樣品製備
  • 檢測方法開發
  • 化合物管理
  • 篩檢與分析
  • 資料管理與整合

第7章 全球實驗室自動化與高通量篩檢市場：依最終使用者分類

  • 製藥和生物技術公司
  • 學術研究機構
  • 臨床實驗室
  • 受託研究機構（CRO）

第8章 全球實驗室自動化與高通量篩檢市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第9章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第10章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第11章：公司簡介

  • Tecan Group Ltd.
  • Hamilton Company
  • Beckman Coulter Life Sciences
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Revvity, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen NV
  • Eppendorf SE
  • SPT Labtech
  • Automata Technologies
  • Hudson Robotics, Inc.
  • BMG LABTECH GmbH
  • Opentrons Labworks Inc.
  • HighRes Biosolutions, Inc.
  • Becton, Dickinson and Company
  • Aurora Biomed Inc.
Product Code: SMRC40188

According to Stratistics MRC, the Global Laboratory Automation & High-Throughput Screening Market is accounted for $34.8 billion in 2026 and is expected to reach $68.9 billion by 2034 growing at a CAGR of 8.9% during the forecast period. Laboratory Automation & High-Throughput Screening combines robotics, automated equipment, software platforms, and analytical technologies to enhance the efficiency and accuracy of laboratory operations. These solutions automate activities such as sample preparation, liquid handling, assay execution, data acquisition, and result analysis. High-throughput screening allows researchers to examine extensive libraries of compounds, samples, and experimental variables within shorter periods. By minimizing manual tasks, these technologies improve workflow consistency, reproducibility, processing capacity, and operational efficiency while accelerating research activities and discovery processes in pharmaceutical, biotechnology, clinical, and academic laboratory settings.

According to NIH's National Center for Advancing Translational Sciences (NCATS), its automated primary screening system has storage capacity for more than 3 million compound wells and approximately 1.5 million assay wells, with multiple assays capable of running in parallel.

Market Dynamics:

Driver:

Increasing demand for laboratory efficiency and productivity

Rising emphasis on laboratory efficiency and productivity is supporting market expansion as organizations seek faster and more reliable workflows. Automation technologies can handle repetitive laboratory activities, reduce human intervention, and maintain consistent processing standards. Pharmaceutical and biotechnology organizations increasingly use these capabilities to shorten experimental timelines and standardize operations. As laboratories prioritize productivity, operational optimization, and reduced processing delays, adoption of automated and high-throughput screening solutions continues to increase across research and testing environments.

Restraint:

High initial investment and implementation costs

Significant upfront expenses associated with laboratory automation can limit market adoption, particularly among organizations operating with restricted budgets. Robotic equipment, automated analyzers, software, infrastructure, and system integration may require considerable financial investment. Additional spending on installation, validation, maintenance, technology upgrades, and workforce training can increase the overall cost of implementation. Furthermore, integrating new automated platforms with established laboratory processes can involve technical complexity, additional resources, and longer implementation periods, potentially slowing the transition toward automated and high-throughput laboratory operations.

Opportunity:

Expansion of automation in emerging markets

Growing adoption of laboratory automation in developing economies offers considerable expansion potential for the market. Increasing pharmaceutical, biotechnology, diagnostic, and academic research activities are encouraging laboratories to improve operational efficiency through automated technologies. Improvements in healthcare infrastructure and investments in research and biotechnology facilities can further accelerate technology adoption. As laboratories modernize across emerging economies, technology providers have opportunities to offer scalable and economical automation solutions that address rising requirements for efficient testing, screening, and research operations.

Threat:

Data security and system vulnerability risks

Cybersecurity concerns can threaten the adoption of connected laboratory automation and high-throughput screening systems. Modern laboratories increasingly use networked instruments, digital platforms, cloud technologies, and centralized data environments, which can create vulnerabilities to unauthorized access and cyber incidents. Security breaches may expose confidential research information, intellectual property, experimental findings, and operational data. Consequently, organizations may need stronger security infrastructure, monitoring, and protection measures, adding costs and technical complexity that could slow adoption of increasingly interconnected laboratory automation solutions.

Covid-19 Impact:

The COVID-19 pandemic accelerated demand for laboratory automation and high-throughput screening as laboratories needed faster testing, greater processing capacity, and reduced dependence on manual procedures. Pharmaceutical and research organizations also increased screening efforts focused on vaccines, treatments, and diagnostic solutions. Equipment deliveries and installations were temporarily affected by supply-chain challenges and operational restrictions. However, the pandemic highlighted the benefits of automation and encouraged greater investment in scalable, efficient laboratory technologies for future research and testing needs.

The automated liquid handling systems segment is expected to be the largest during the forecast period

The automated liquid handling systems segment is expected to account for the largest market share during the forecast period because they support essential laboratory processes involving precise and reliable movement of liquids. By automating pipetting, dispensing, dilution, and sample preparation, these systems minimize repetitive manual work and improve consistency. Their usefulness across drug discovery, pharmaceutical development, biotechnology, genomics, and clinical testing contributes to broad utilization. Compatibility with robotic equipment and high-throughput screening platforms also strengthens their role in automated workflows.

The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the contract research organizations (CROs) segment is predicted to witness the highest growth rate, positioned for strong growth as pharmaceutical and biotechnology businesses increasingly rely on external providers for research and testing requirements. CROs need scalable technologies to handle extensive sample volumes, experimental workloads, and screening projects efficiently. Automation enables these organizations to increase processing capacity, minimize repetitive tasks, maintain standardized procedures, and shorten project timelines. Rising outsourcing of drug discovery, preclinical studies, analytical services, and specialized research activities is further encouraging CROs to adopt sophisticated laboratory automation and high-throughput screening technologies.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of its mature pharmaceutical and biotechnology industries, advanced research capabilities, and widespread use of automated laboratory solutions. Numerous research organizations, clinical laboratories, and contract research organizations across the region depend on automation to improve laboratory processes. In addition, developed healthcare infrastructure and a strong presence of laboratory technology companies contribute to North America's leading position across automation and high-throughput screening applications.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as pharmaceutical, biotechnology, and research activities continue expanding. Increasing investments in drug development, clinical studies, genomics, and sophisticated diagnostic capabilities are creating stronger demand for laboratory automation. Improvements in healthcare infrastructure, greater use of advanced research technologies, and growing laboratory service outsourcing are further supporting adoption. Expanding biotechnology centers and strengthening research ecosystems across the region are encouraging laboratories to implement automated platforms that enhance efficiency, scalability, and high-throughput screening capabilities.

Key players in the market

Some of the key players in Laboratory Automation & High-Throughput Screening Market include Tecan Group Ltd., Hamilton Company, Beckman Coulter Life Sciences, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Revvity, Inc., F. Hoffmann-La Roche Ltd., Qiagen N.V., Eppendorf SE, SPT Labtech, Automata Technologies, Hudson Robotics, Inc., BMG LABTECH GmbH, Opentrons Labworks Inc., HighRes Biosolutions, Inc., Becton, Dickinson and Company and Aurora Biomed Inc.

Key Developments:

In January 2026, BD (Becton, Dickinson and Company) and Ypsomed are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak(TM) XtraFlow(TM) Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate(R) 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large-volume subcutaneous self-injections.

In October 2025, Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials. The deal includes potential additional earnout and other payments contingent on future performance. Clario's platform integrates clinical trial endpoint data from devices, sites, and patients, enabling pharmaceutical and biotechnology companies to digitally collect, manage, and analyze clinical evidence across all phases of drug development.

Product Types Covered:

  • Automated Liquid Handling Systems
  • Automated Plate Readers
  • Automated Storage & Retrieval Systems
  • Robotic Systems
  • Laboratory Information Management Systems (LIMS)
  • High-Throughput Screening Instruments

Applications Covered:

  • Sample Preparation
  • Assay Development
  • Compound Management
  • Screening & Analysis
  • Data Management & Integration

End Users Covered:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Clinical Laboratories
  • Contract Research Organizations (CROs)

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Laboratory Automation & High-Throughput Screening Market, By Product Type

  • 5.1 Automated Liquid Handling Systems
  • 5.2 Automated Plate Readers
  • 5.3 Automated Storage & Retrieval Systems
  • 5.4 Robotic Systems
  • 5.5 Laboratory Information Management Systems (LIMS)
  • 5.6 High-Throughput Screening Instruments

6 Global Laboratory Automation & High-Throughput Screening Market, By Application

  • 6.1 Sample Preparation
  • 6.2 Assay Development
  • 6.3 Compound Management
  • 6.4 Screening & Analysis
  • 6.5 Data Management & Integration

7 Global Laboratory Automation & High-Throughput Screening Market, By End User

  • 7.1 Pharmaceutical & Biotechnology Companies
  • 7.2 Academic & Research Institutes
  • 7.3 Clinical Laboratories
  • 7.4 Contract Research Organizations (CROs)

8 Global Laboratory Automation & High-Throughput Screening Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 Tecan Group Ltd.
  • 11.2 Hamilton Company
  • 11.3 Beckman Coulter Life Sciences
  • 11.4 Thermo Fisher Scientific Inc.
  • 11.5 Agilent Technologies, Inc.
  • 11.6 Bio-Rad Laboratories, Inc.
  • 11.7 Revvity, Inc.
  • 11.8 F. Hoffmann-La Roche Ltd.
  • 11.9 Qiagen N.V.
  • 11.10 Eppendorf SE
  • 11.11 SPT Labtech
  • 11.12 Automata Technologies
  • 11.13 Hudson Robotics, Inc.
  • 11.14 BMG LABTECH GmbH
  • 11.15 Opentrons Labworks Inc.
  • 11.16 HighRes Biosolutions, Inc.
  • 11.17 Becton, Dickinson and Company
  • 11.18 Aurora Biomed Inc.

List of Tables

  • Table 1 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Automated Liquid Handling Systems (2023-2034) ($MN)
  • Table 4 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Automated Plate Readers (2023-2034) ($MN)
  • Table 5 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Automated Storage & Retrieval Systems (2023-2034) ($MN)
  • Table 6 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Robotic Systems (2023-2034) ($MN)
  • Table 7 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Laboratory Information Management Systems (LIMS) (2023-2034) ($MN)
  • Table 8 Global Laboratory Automation & High-Throughput Screening Market Outlook, By High-Throughput Screening Instruments (2023-2034) ($MN)
  • Table 9 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Application (2023-2034) ($MN)
  • Table 10 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Sample Preparation (2023-2034) ($MN)
  • Table 11 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Assay Development (2023-2034) ($MN)
  • Table 12 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Compound Management (2023-2034) ($MN)
  • Table 13 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Screening & Analysis (2023-2034) ($MN)
  • Table 14 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Data Management & Integration (2023-2034) ($MN)
  • Table 15 Global Laboratory Automation & High-Throughput Screening Market Outlook, By End User (2023-2034) ($MN)
  • Table 16 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 17 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
  • Table 18 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Clinical Laboratories (2023-2034) ($MN)
  • Table 19 Global Laboratory Automation & High-Throughput Screening Market Outlook, By Contract Research Organizations (CROs) (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.